Gemfibrozil
NDC 50268-350, Gemfibrozil, tablet, from AvPAK.
- Product NDC
- 50268-350
- Status
- Listed
- Labeler
- AvPAK
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA077836
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50268-350 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GEMFIBROZIL600 mg/1
Pharmacologic classes
PPAR alpha [CS]; Peroxisome Proliferator Receptor alpha Agonist [EPC]; Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50268-350-15 | 50268035015 | 50 BLISTER PACK in 1 BOX (50268-350-15) / 1 TABLET in 1 BLISTER PACK (50268-350-11) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/3ebb5947-1fe5-9740-6a4b-1f8b577b2711NADAC price for package 50268035015
GET /v1/drugs/nadac/50268035015
Use it
Look up 50268-350 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50268-350 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50268-350. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.